2013
DOI: 10.1002/bdd.1837
|View full text |Cite
|
Sign up to set email alerts
|

In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes

Abstract: Obovatol, a major constituent of the leaves of Magnolia obovata Thunb, is known to inhibit nuclear factor-κB activity and arachidonic acid-induced platelet aggregation. This study was performed to identify the metabolites of obovatol in human liver microsomes. Human liver microsomes incubated with obovatol in the presence of NADPH and/or UDPGA resulted in the formation of six metabolites, M1-M6. M1 and M2 were identified as hydroxyobovatol, on the basis of liquid chromatography/tandem mass spectrometric (LC-MS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…While lignan exhibited noncompetitive inhibition toward CYP1A2, it proved to be a competitive inhibitor with respect to the other isoforms . In an alternative work, a biophenyl ether lignan obovatol was also shown to inhibit CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP2C19 in vitro , the IC 50 values being 4.4, 13.9, 11.1, 3.3, and 0.8 μM, respectively . The strong potential of lignans to inhibit the catalytic activity of CYP enzymes responsible for drug metabolism suggests the possibility for pharmacokinetic drug interactions.…”
Section: Interactions Between Polyphenols and Cyp: Direct Binding And...mentioning
confidence: 94%
See 1 more Smart Citation
“…While lignan exhibited noncompetitive inhibition toward CYP1A2, it proved to be a competitive inhibitor with respect to the other isoforms . In an alternative work, a biophenyl ether lignan obovatol was also shown to inhibit CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP2C19 in vitro , the IC 50 values being 4.4, 13.9, 11.1, 3.3, and 0.8 μM, respectively . The strong potential of lignans to inhibit the catalytic activity of CYP enzymes responsible for drug metabolism suggests the possibility for pharmacokinetic drug interactions.…”
Section: Interactions Between Polyphenols and Cyp: Direct Binding And...mentioning
confidence: 94%
“…137 In an alternative work, a biophenyl ether lignan obovatol was also shown to inhibit CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP2C19 in vitro, the IC 50 values being 4.4, 13.9, 11.1, 3.3, and 0.8 μM, respectively. 140 The strong potential of lignans to inhibit the catalytic activity of CYP enzymes responsible for drug metabolism suggests the possibility for pharmacokinetic drug interactions. The compounds exhibiting mechanism-based inactivation of CYP enzymes and their respective K I ad k inact values are summarized in Table 3.…”
Section: Interactions Between Polyphenols and Cyp: Direct Binding And...mentioning
confidence: 99%
“…Honokiol weakly inhibited CYP3A-mediated midazolam 1'-hydroxylation with IC 50 values of 97.3 μM. This was not an unusual finding, given that obovatol, a biphenyl ether lignan, also exhibits an inhibitory effect towards CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP2C19 with IC 50 values of 4.4, 13.9, 11.1, 3.3, and 0.8 μM, respectively [37]. At 100 μM, honokiol produced negligible inhibition of CYP2A6-mediated coumarin 7-hydroxylation.…”
Section: Resultsmentioning
confidence: 94%
“…The identification of magnolol and honokiol was performed by comparing the fragmentation of their mass spectra with the records in the METLIN online database. The mass spectrum of obovatol was not available from the METLIN database; however, this neolignan was identified based on data published in a paper [ 12 ], in which the fragmentation spectrum of obovatol was published.…”
Section: Resultsmentioning
confidence: 99%